Benefits and Accuracy of Real-Time CGM in Children and Adolescents with Type 1 Diabetes Attending Summer Camp: 2nd year
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Dexcom G7 real-time continuous glucose monitoring (rt-CGM) system demonstrated improved accuracy and higher usefulness compared to the G6 in a type 1 diabetes camp setting. This new rt-CGM tool enhanced glucose management for participants during the camp session.
Area Of Science
- Endocrinology
- Biomedical Engineering
- Pediatric Diabetes Management
Background
- Previous real-time continuous glucose monitoring (rt-CGM) use (Dexcom G6) in type 1 diabetes summer camps showed high utility but lacked sufficient accuracy.
- The need for accurate and user-friendly glucose monitoring is critical in managing type 1 diabetes, especially in camp environments.
Purpose Of The Study
- To evaluate the usefulness, recommendation rates, and accuracy of the new Dexcom G7 rt-CGM system in a pediatric type 1 diabetes camp setting.
- To compare the performance of Dexcom G7 against the previously used Dexcom G6 system.
Main Methods
- The Dexcom G7 system was used for sensor glucose (SG) monitoring for 6 days prior to and during a 2-day camp session.
- Usefulness and recommendation were assessed via questionnaires among 21 children with type 1 diabetes and 52 healthcare providers (HCPs).
- CGM performance metrics, including Mean Absolute Relative Difference (MARD) and coefficient of variation, were analyzed.
Main Results
- Dexcom G7 received high ratings for sensor insertion, SG variation visualization, and convenience, with significantly higher usefulness and recommendation scores among campers than G6.
- G7 demonstrated improved accuracy with a lower MARD (11.3% on camp, 11.0% off camp) compared to G6 (16.0% on camp, 19.7% off camp).
- Glycemic management metrics and graphical analyses indicated sufficient accuracy, with better performance observed during the camp session.
Conclusions
- The Dexcom G7 rt-CGM system is rated higher in usefulness and recommendation by participants compared to the G6.
- G7 offers improved accuracy and is a valuable rt-CGM tool for type 1 diabetes management in a camp setting.
- Multifaceted efforts by HCPs significantly enhanced glucose management during the camp period.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...